363 research outputs found
Peningkatan Pembelajaran Mata Kuliah Terjemahan Perancis-Indonesia (Version I) Jurusan Pendidikan Bahasa Perancis FBS UNY dengan Project-Based Learning (PBL)
Recommended from our members
Osteogenic preconditioning in perfusion bioreactors improves vascularization and bone formation by human bone marrow aspirates.
Cell-derived extracellular matrix (ECM) provides a niche to promote osteogenic differentiation, cell adhesion, survival, and trophic factor secretion. To determine whether osteogenic preconditioning would improve the bone-forming potential of unfractionated bone marrow aspirate (BMA), we perfused cells on ECM-coated scaffolds to generate naïve and preconditioned constructs, respectively. The composition of cells selected from BMA was distinct on each scaffold. Naïve constructs exhibited robust proangiogenic potential in vitro, while preconditioned scaffolds contained more mesenchymal stem/stromal cells (MSCs) and endothelial cells (ECs) and exhibited an osteogenic phenotype. Upon implantation into an orthotopic calvarial defect, BMA-derived ECs were present in vessels in preconditioned implants, resulting in robust perfusion and greater vessel density over the first 14 days compared to naïve implants. After 10 weeks, human ECs and differentiated MSCs were detected in de novo tissues derived from naïve and preconditioned scaffolds. These results demonstrate that bioreactor-based preconditioning augments the bone-forming potential of BMA
Role of carbon cycle observations and knowledge in carbon management
Author Posting. © Annual Reviews, 2003. This article is posted here by permission of Annual Reviews for personal use, not for redistribution. The definitive version was published in Annual Review of Environment and Resources 28 (2003): 521-558, doi:10.1146/annurev.energy.28.011503.163443.Agriculture and industrial development have led to inadvertent changes
in the natural carbon cycle. As a consequence, concentrations of carbon dioxide and other greenhouse gases have increased in the atmosphere and may lead to changes in
climate. The current challenge facing society is to develop options for future management
of the carbon cycle. A variety of approaches has been suggested: direct reduction
of emissions, deliberate manipulation of the natural carbon cycle to enhance sequestration,
and capture and isolation of carbon from fossil fuel use. Policy development to
date has laid out some of the general principles to which carbon management should
adhere. These are summarized as: how much carbon is stored, by what means, and
for how long. To successfully manage carbon for climate purposes requires increased
understanding of carbon cycle dynamics and improvement in the scientific capabilities
available for measurement as well as for policy needs. The specific needs for scientific
information to underpin carbon cycle management decisions are not yet broadly
known. A stronger dialogue between decision makers and scientists must be developed
to foster improved application of scientific knowledge to decisions. This review focuses
on the current knowledge of the carbon cycle, carbon measurement capabilities
(with an emphasis on the continental scale) and the relevance of carbon cycle science
to carbon sequestration goals.The National Center for Atmospheric Research is supported by the National Science
Foundation
Computational Modeling of Silicate Glasses: A Quantitative Structure-Property Relationship Perspective
This article reviews the present state of Quantitative Structure-Property
Relationships (QSPR) in glass design and gives an outlook into future developments.
First an overview is given of the statistical methodology, with particular emphasis
to the integration of QSPR with molecular dynamics simulations to derive informative
structural descriptors. Then, the potentiality of this approach as a tool for
interpretative and predictive purposes is highlighted by a number of recent inspiring
applications
The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target
Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes
<p>Abstract</p> <p>Background</p> <p>MMP-13 and IGFBP-5 are important factors involved in osteoarthritis (OA). We investigated whether two highly predicted microRNAs (miRNAs), miR-140 and miR-27a, regulate these two genes in human OA chondrocytes.</p> <p>Methods</p> <p>Gene expression was determined by real-time PCR. The effect of each miRNA on IGFBP-5 and MMP-13 expression/production was evaluated by transiently transfecting their precursors (pre-miRNAs) and inhibitors (anti-miRNAs) into human OA chondrocytes. Modulation of IGFBP-5, miR-140 and miR-27a expression was determined upon treatment of OA chondrocytes with cytokines and growth factors.</p> <p>Results</p> <p>IGFBP-5 was expressed in human chondrocytes with its level significantly lower (p < 0.04) in OA. Five computational algorithms identified miR-140 and miR-27a as possible regulators of MMP-13 and IGFBP-5 expression. Data showed that both miRNAs were expressed in chondrocytes. There was a significant reduction (77%, p < 0.01) in miR-140 expression in OA compared to the normal chondrocytes, whereas miR-27a expression was only slightly decreased (23%). Transfection with pre-miR-140 significantly decreased (p = 0.0002) and with anti-miR-140 significantly increased (p = 0.05) IGFBP-5 expression at 24 hours, while pre-miR-27a did not affect either MMP-13 or IGFBP-5. Treatment with anti-miR-27a, but not with anti-miR-140, significantly increased the expression of both MMP-13 (p < 0.05) and IGFBP-5 (p < 0.01) after 72 hours of incubation. MMP-13 and IGFBP-5 protein production followed the same pattern as their expression profile. These data suggest that IGFBP-5 is a direct target of miR-140, whereas miR-27a down-regulates, likely indirectly, both MMP-13 and IGFBP-5.</p> <p>Conclusion</p> <p>This study is the first to show the regulation of these miRNAs in human OA chondrocytes. Their effect on two genes involved in OA pathophysiology adds another level of complexity to gene regulation, which could open up novel avenues in OA therapeutic strategies.</p
The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol
- …